昭衍新药拟回购注销3.4401万股限制性股票 总股本将相应减少

新浪财经
12 May

昭衍新药于2025年5月13日发布公告,披露关于回购注销部分限制性股票并通知债权人相关事宜。因激励对象变动触发回购注销公司于2023年3月30日召开的第四届董事会第二次会议,审议通过了《关于回购注销2019年股票期权与限制性股票激励计划部分限制性股票的议案》《关于回购注销2021年A股限制性股票激励计划部分限制性股票的议案》;2023年4月27日召开的第四届董事会第三次会议,再次审议通过《关于回购...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10